FDA Withdraws Approval of 34 New Drug Applications from Endo Operations Limited and Other Applicants

Summary

The US Food and Drug Administration (FDA) has withdrawn the approval of 34 new drug applications from Endo Operations Limited and other applicants, following written notifications that the drug products are no longer commercially available.